CVUAE 2026

The 16th Annual Case-Based Approach to Controversies in Cardiovascular Diseases

February 7 & 8, 2026

Creekside Hotel, Dubai – United Arab Emirates.

The 16th Annual Case-Based Approach to Controversies in Cardiovascular Diseases brings together global experts for two days of immersive, case-driven learning focused on the latest challenges, advances, and clinical decision-making in cardiovascular care.

CVUAE 2026, co-sponsored by the Cleveland Clinic and Mayo Clinic, offers an in-depth review of current state-of-the-art practices in cardiovascular medicine. All sessions are presented in a real-world, case-based format designed to encourage active participation, interactive discussion, and meaningful debate between faculty and attendees.

This program is designed for all healthcare professionals involved in the management of cardiovascular diseases, including cardiologists, cardiac surgeons, residents, fellows, and nurses.

Summary:

Topics

• Essentials of Coronary Artery Disease
• Structural Heart Disease
• Heart Failure and Critical Care Cardiology
• Contemporary Management of AF
• Test Your Skills with EKG and Imaging Cases

Target Audience:

• ⁠ Cardiologists & Cardiac Surgeons
• Fellows and Residents in Cardiovascular and Cardiac Surgery training programs
• Nurses, Physician Assistants and other Allied Health Professionals involved in the care of cardiovascular patients
• Medical students with an interest in Cardiovascular Medicine
• Internists & General Practitioners

Learning Objectives:

• Define and describe current strategies for the prevention and management of hyperlipidemia, hypertension, and cardiovascular protection with Type 2 diabetes.
• Critically appraise practical applications for the management of tricuspid disease and degenerative mitral regurgitation (MR), including the role of guideline-directed medical therapy (GDMT) and surgical techniques for MR.
• Analyze the clinical applications and treatments for the management of aortic valve disease.
• Describe management strategies for new-onset AFib, including interventional options for stroke risk.
• Apply current guideline recommendations for the treatment of heart failure and cardiomyopathy, including the diagnosis and management of hypertrophic cardiomyopathy and amyloid
• Examine management strategies for simple and complex CAD